Stock listing

Munich:DMN Diamyd Medical AB Aktie

German listing (Munich) of Diamyd Medical AB · home listing Stockholm:DMYDB

Follow Diamyd Medical AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:DMYD_B

1.01 SEK -0.08 (-7.0%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:DMYD_B

Past 3 months -9.5% · daily closes, Jul 7, 2026 – Oct 19, 2026, adjusted for splits
Day range
1.01 – 1.08 SEKOct 19, 2026
Volume
193,576 sharesOct 19, 2026
Market cap
157.2M SEKAt the close on Oct 19, 2026 · price × 155.0M shares outstanding
Diamyd Medical AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Frankfurt:DMN€0.078 EUR+0.006 (+9.1%)—€0.078€0.078€0.078€0.071Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · OMXSTO:DMYD_B · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
1.014-0.076-7.0%1.081.081.014193,576
1.09+0.07+6.9%1.0041.090.99325,895
1.02-0.01-1.0%1.031.0341.00799,289
1.03-0.018-1.7%1.0521.0681.012172,285
1.048+0.034+3.4%1.031.0821.006744,901
1.014+0.034+3.5%0.981.0380.98796,603
0.98+0.021+2.2%0.9480.9890.921894,924
0.959+0.017+1.8%0.950.9890.919626,189
0.942-0.058-5.8%1.0321.0320.9241,534,805
1.000.000.0%0.9991.030.9951,088,734
1.00-0.016-1.6%1.0041.030.9951,102,206
1.016-0.006-0.6%1.0161.0281.004243,214
1.022-0.008-0.8%1.0361.051.016436,731
1.03+0.01+1.0%1.0281.0361.01236,025
1.02+0.012+1.2%1.0121.111.001,021,231
1.008-0.034-3.3%1.0621.0620.9921,089,661
1.042-0.108-9.4%1.1521.181.032,827,784
1.15+0.12+11.7%1.0321.401.0085,461,531
1.03+0.008+0.8%1.031.0321.0074,402
1.022-0.004-0.4%1.011.071.00412,425
1.026+0.016+1.6%1.0081.030.992259,177
1.01+0.006+0.6%1.001.0120.991195,674
1.004-0.014-1.4%1.0161.0180.98565,632
1.018+0.004+0.4%1.0141.0240.99935,911
1.014-0.002-0.2%1.0021.0240.985401,278
1.016+0.012+1.2%1.0021.020.99549,873
1.004+0.002+0.2%1.0221.0340.9991,644,126
1.002-0.002-0.2%0.9991.030.9681,225,816
1.004-0.014-1.4%1.0181.0261.00794,165
1.018-0.016-1.5%1.0241.0341.004217,776
1.034-0.006-0.6%1.041.0541.01477,356
1.04+0.01+1.0%1.0241.051.01247,358
1.03-0.026-2.5%1.031.061.02344,152
1.056+0.036+3.5%1.021.0561.02303,341
1.02-0.004-0.4%1.031.0441.014200,646
1.024-0.01-1.0%1.0161.041.002278,080
1.034+0.022+2.2%1.0141.0341.01213,822
1.012-0.014-1.4%1.0221.0481.012197,041
1.0260.000.0%1.0381.051.01717,693
1.026-0.066-6.0%1.0661.0881.02336,717
1.092+0.09+9.0%1.0221.0921.001,338,594
1.002-0.018-1.8%1.0221.041.002533,667
1.02-0.016-1.5%1.0041.0241.00316,182
1.036+0.014+1.4%1.0241.0361.00210,440
1.022+0.01+1.0%1.0021.0460.9951,389,865
1.012-0.01-1.0%1.0041.0221.00178,217
1.022+0.002+0.2%1.021.031.00293,741
1.02-0.014-1.4%1.021.041.00572,088
1.034+0.01+1.0%1.0241.051.02893,403
1.0240.000.0%1.0161.0481.002287,804
1.024+0.014+1.4%1.0161.030.998246,330
1.01-0.004-0.4%1.0161.0461.01188,235
1.014-0.032-3.1%1.0381.0461.012198,912
1.046+0.024+2.3%1.031.051.012182,844
1.022-0.014-1.4%1.0381.0381.02234,055
1.036+0.006+0.6%1.0281.0481.014405,271
1.030.000.0%1.041.0620.998840,175
1.030.000.0%1.031.0461.01211,578
1.03-0.002-0.2%1.0421.0421.002284,172
1.032+0.022+2.2%1.001.0480.999285,216
1.01-0.022-2.1%1.031.030.9451,425,264
1.032+0.002+0.2%1.0341.0541.026251,373
1.03-0.018-1.7%1.031.071.02130,558
1.048+0.008+0.8%1.0641.0761.02135,581
1.04-0.04-3.7%1.071.0761.036345,587
1.08-0.02-1.8%1.0721.0961.058266,378
Ticker
Munich:DMN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Munich
Currency
EUR

What changed lately

Calls

Replays

  • Diamyd Medical (Stockholm:DMYD B) Q2 2026 Earnings Call

    Wed, Mar 25, 2026 · 4:00 AM ET

    Watch Transcript

  • Diamyd Medical (Stockholm:DMYD B) Q4 2025 Earnings Call

    Wed, Oct 08, 2025 · 2:30 AM ET

    Watch Transcript

  • Diamyd Medical (Stockholm:DMYD B) Q3 2025 Earnings Call

    Fri, Jul 25, 2025 · 2:00 AM ET

    Watch Transcript

Latest news

Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial

Mar 23, 2026

Diamyd Medical announces finalization of database for interim analysis in Phase 3 DIAGNODE-3 trial

Feb 24, 2026

Diamyd Medical receives Notice of Allowance for key retogatein US patent

Feb 9, 2026

Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes Phase 3 trial following FDA alignment and guidance

Dec 29, 2025

All Diamyd Medical AB news

Decks

Diamyd Medical AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
4 in the last 12 months · 4 in all · newest Mar 23, 2026 · oldest 2025
Calls
7 calls with a replay · 7 with a transcript · latest Mar 25, 2026
Decks
6 decks · latest March 2026

Where Diamyd Medical AB is listed

ListingExchangeCountryCurrency
Stockholm:DMYDB · Home listingStockholmSwedenSEK
gettex:DMNgettexGermanyEUR
LS Exchange:A1T90LLS ExchangeGermanyEUR
Lang & Schwarz:A1T90LLang & SchwarzGermanyEUR
Frankfurt:DMNFrankfurtGermanyEUR
OTC:DYMDFOTCUnited StatesUSD
Munich:DMN · This pageMunichGermanyEUR

Log in to ask 6ix AI your own questions about Diamyd Medical AB.